Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:ADK)

DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange

GlobeNewswire 10 days ago

DIAGNOS Announces Closing of Private Placement

GlobeNewswire October 25, 2024

DIAGNOS Announces the Engagement of Market Maker Consultant

GlobeNewswire October 17, 2024

DIAGNOS Announces Grant of Stock Options

GlobeNewswire October 3, 2024

DIAGNOS Announces Voting Results of Meeting of Shareholders

GlobeNewswire September 26, 2024

DIAGNOS Announces Variation in One Insider Ownership

GlobeNewswire September 23, 2024

DIAGNOS Announces Closing of Private Placement

GlobeNewswire September 20, 2024

DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders

GlobeNewswire August 22, 2024

DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada

GlobeNewswire August 20, 2024
View More News ››

Opinion & Analysis (TSXV:ADK)

Diagnos increases footprint, and endorsements mount for AI tech that averts illness

Stockhouse Editorial June 4, 2020

DIAGNOS poised for parabolic move as first of new cardio AI Applications comes to market

Stockhouse Editorial May 5, 2020

DIAGNOS Inc. expands artificial intelligence platform, first mover in $386 billion/yr market

Stockhouse Editorial September 21, 2017

DIAGNOS Inc. adoption curve to accelerate applying AI in healthcare

Stockhouse Editorial May 31, 2017

DIAGNOS applying artificial intelligence in diabetes market, vertical growth trajectory in sight

Stockhouse Editorial December 2, 2016
View More Opinion ››

Bullboard Posts (TSXV:ADK)

RE:TARGET PRICE $1.50

No doubt with the latest news more essilor deal
slipdan - August 20, 2024

TARGET PRICE $1.50

DIAGNOS (ADK) Stock Forecast and Price Target 2024 (marketbeat.com)
BLUEBERRY5 - August 20, 2024

A few things are coming

The volume increases from day to day he stirs a few things 
slipdan - August 20, 2024

DIAGNOS to expedite application for Medical Device License

BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a...
Betteryear2 - April 16, 2024

RE:Echelon Wealth Top Picks Q1, 2024

The best is to come those who get rid of their actions will regret it in the near future!
slipdan - February 2, 2024

RE:Echelon Wealth Top Picks Q1, 2024

Not such an idiot....great listen here! Possible takeout by Essilor in next 18-24 months.....patience my friends.
hotginger - February 2, 2024
View more Bullboard ››

Mandalay Resources Corp.

Mandalay Resources Corp.

Mandalay Resources Corporation is a Canada-based natural resource company with producing assets in Australia (Costerfield ...
View More »